Forbearance Agreements in the Biotechnology Industry

26 Contracts & Agreements

Browse by Company

Allarity Therapeutics, Inc. (2 contracts)
Alliqua BioMedical, Inc. (4)
Arsanis, Inc. (1)
Blue Water Vaccines Inc. (3)
GT Biopharma, Inc. (4)
GX Acquisition Corp. (2)
TG THERAPEUTICS, INC. (1)
Trovagene, Inc. (1)
U.S. Stem Cell, Inc. (1)
VBI Vaccines Inc (7)

Recent Contracts

Waiver and Amendment No. 1 to Forbearance Agreement, dated November 26, 2024, between the Company and Veru (Blue Water Vaccines Inc., Filed With SEC on December 3, 2024)
Amended and Restated Forbearance Agreement between the Company and Veru, dated September 19, 2024 (Blue Water Vaccines Inc., Filed With SEC on September 20, 2024)
Forbearance Agreement, dated April 24, 2024, between the Company and Veru (Blue Water Vaccines Inc., Filed With SEC on April 26, 2024)
Extension to Forbearance Agreement, dated February 6, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
Extension to Forbearance Agreement, dated January 23, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
Extension to Forbearance Agreement, dated January 9, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
Extension to Forbearance Agreement, dated December 26, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
Extension to Forbearance Agreement, dated December 12, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
Extension to Forbearance Agreement, dated November 28, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
Forbearance Agreement, dated March 13, 2024, between Celularity Inc. and C.V. Starr & Co. Inc (GX Acquisition Corp., Filed With SEC on March 15, 2024)
Forbearance Agreement, dated March 13, 2024, between Celularity Inc. and Resorts World Inc Pte Ltd (GX Acquisition Corp., Filed With SEC on March 15, 2024)
Forbearance Agreement, dated November 13, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on November 14, 2023)
First Amendment to Forbearance Agreement and Waiver (Allarity Therapeutics, Inc., Filed With SEC on June 10, 2022)
Forbearance Agreement and Waiver (Allarity Therapeutics, Inc., Filed With SEC on May 6, 2022)
Form of Second Amendment and Extension of Standstill and Forbearance Agreement (GT Biopharma, Inc., Filed With SEC on February 2, 2021)
STANDSTILL AND FORBEARANCE AGREEMENT (GT Biopharma, Inc., Filed With SEC on June 23, 2020)
Forbearance Agreement, dated August 8, 2018, by and between the Registrant and Silicon Valley Bank (Arsanis, Inc., Filed With SEC on August 13, 2018)
SECOND FORBEARANCE AGREEMENT (Alliqua BioMedical, Inc., Filed With SEC on August 10, 2017)
AMENDMENT NO.2 TO FORBEARANCE AND AMENDMENTAGREEMENT (Alliqua BioMedical, Inc., Filed With SEC on May 1, 2017)
AMENDMENT NO.1 TO FORBEARANCE AND AMENDMENTAGREEMENT (Alliqua BioMedical, Inc., Filed With SEC on March 13, 2017)
FORBEARANCE AND AMENDMENTAGREEMENT (Alliqua BioMedical, Inc., Filed With SEC on January 30, 2017)
LIMITED WAIVER AND FORBEARANCE AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on November 7, 2014)
STANDSTILL AND FORBEARANCE AGREEMENT (GT Biopharma, Inc., Filed With SEC on May 21, 2012)
WAIVERAND FORBEARANCE AGREEMENT (TG THERAPEUTICS, INC., Filed With SEC on February 14, 2011)
STANDSTILL AND FORBEARANCE AGREEMENT (GT Biopharma, Inc., Filed With SEC on October 9, 2009)
FORBEARANCE AGREEMENT (Trovagene, Inc., Filed With SEC on February 4, 2009)